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ABSTRACT
Global demethylation is required for early zygote
development to establish stem cell pluripotency,
yet our findings reiterate this epigenetic reprogram-
ming event in somatic cells through ectopic intro-
duction of mir-302 function. Here, we report that
induced mir-302 expression beyond 1.3-fold of the
concentration in human embryonic stem (hES) H1
and H9 cells led to reprogramming of human hair
follicle cells (hHFCs) to induced pluripotent stem
(iPS) cells. This reprogramming mechanism func-
tioned through mir-302-targeted co-suppression of
four epigenetic regulators, AOF2 (also known as
KDM1 or LSD1), AOF1, MECP1-p66 and MECP2.
Silencing AOF2 also caused DNMT1 deficiency and
further enhanced global demethylation during
somatic cell reprogramming (SCR) of hHFCs.
Re-supplementing AOF2 in iPS cells disrupted
such global demethylation and induced cell differ-
entiation. Given that both hES and iPS cells highly
express mir-302, our findings suggest a novel link
between zygotic reprogramming and SCR, providing
a regulatory mechanism responsible for global
demethylation in both events. As the mechanism
of conventional iPS cell induction methods
remains largely unknown, understanding this
microRNA (miRNA)-mediated SCR mechanism may
shed light on the improvements of iPS cell
generation.
INTRODUCTION
Somatic cell reprogramming (SCR) requires global DNA
demethylation to reset cell stemness, yet the mechanism
underlying this epigenetic event is unclear. Current
understanding is limited by co-transfection of three or
four speciﬁc transcription factors, either Oct3/4–Sox2–
Klf4–cMyc or Oct3/4–Sox2–Nanog–Lin28, to promote
induced pluripotent stem (iPS) cell formation (1–3).
Among these reprogramming factors, POU class
5 homeobox 1 (Oct3/4) and sex determining region
Y-box 2 (Sox2) are essential. Recent studies found that
both Oct4 and Sox2 are also crucial for expressing
mir-302 in human embryonic stem (hES) cells (4,5).
Mir-302 belongs to a class of small, non-coding RNAs
known as microRNAs (miRNA) that function as cyto-
plasmic gene silencers by suppressing translation of
targeted messenger RNAs (mRNA). The majority of
mir-302-targeted genes are transcripts of developmental
signals and oncogenes (6); nevertheless, their interactions
and overall functions remain unknown. The genomic
sequence encoding mir-302 is located in the 4q25 locus
of human chromosome 4, a conserved region frequently
associated with longevity (7). In humans, mir-302 is pre-
dominantly expressed in hES and iPS cells, but not in
differentiated cells (8,9). Loss of mir-302 has been
observed prior to hES cell differentiation and proliferation
during early embryonic development (8). Analogously in
mice, its homologous mir-291/294/295 family presents a
similar expression proﬁle (10). Therefore, it is conceivable
that embryonic stem cell-speciﬁc miRNAs such as mir-302
and mir-291/294/295 play a pivotal role in regulating cell
stemness and pluripotency, whose functions may be
applied to enhance the efﬁciency of SCR for iPS cell
generation.
The initiation of SCR involves a highly coordinated
DNA demethylation and histone methylation mechanism
thatisable toalter agenome-wide scale of chromatin struc-
ture and gene activity. To this, mir-302 may silence certain
epigenetic regulators to affect the status of genomic DNA
methylation. Utilizing high throughput analysis with
online miRNA-target prediction programs
TARGETSCAN (http://www.targetscan.org/) and
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that lysine-speciﬁc histone demethylases (namely AOF,
KDM or LSD) and methyl CpG-binding proteins
(MECP) are two major groups of the epigenetic regula-
tors targeted by mir-302. AOF contains two familial
members AOF1 and AOF2, both of which function to
repress gene transcription by demethylating histone 3
on lysine 4 (H3K4) (11–13). Inhibition of AOF2 by its an-
tagonisttranylcypromineaugmentsH3K4methylationand
stimulates Oct3/4 expression in embryonal carcinoma cells
(11,12). In transgenic knockout mice, loss of either AOF1
or AOF2 substantially increases H3K4 methylation
(13,14). AOF1-knockout mice demonstrate normal body
development but fail to set up de novo DNA methylation
imprints during oogenesis (13), while AOF2 deﬁciency
causes embryonic lethality due to a progressive loss of
genomic DNA methylation and lack of global cell differ-
entiation (14). As a result, silencing of both AOF1 and
AOF2 is likely to be sufﬁcient in inducing global DNA
demethylation. Our recent studies further showed that
ectopic expression of the whole mir-302 familial cluster
induced not only global demethylation via silencing
MECP1-p66 and MECP2 but also the co-expression of
Oct3/4–Sox2–Nanog genes, which led to the
reprogramming of both normal and cancerous human
skin cells into a hES-like pluripotent state (6,15). A
similar mir-302 transfection approach was also shown to
increaseOct3/4–Nanogco-expressionby2-foldinhEScells
(16). Taken together, these ﬁndings suggest that mir-302
may concurrently suppress AOF1/2 and MECP1/2 to
induce global demethylation and to activate the
co-expression of hES-speciﬁc genes required for SCR.
However, a critical link between mir-302 and AOF1/2 is
still missing.
MiRNA concentration determines the efﬁciency of its
gene targeting. To assess this dose-dependent mir-302
effect on AOF1/2 silencing and global demethylation, we
adopted a novel inducible pTet-On-tTS-miR302s
expression vector (Figure 1A) in conjunction with electro-
poration delivery to reprogram normal human hair follicle
cells (hHFCs) isolated from the dermal papilla region.
Skin hHFCs were chosen due to their accessibility and
abundance in differentiated mesenchymal lineage cells,
such as keratinocytes, melanocytes and ﬁbroblasts. We
also mimicked the natural mir-302 expression pattern by
expressing all four native mir-302 familial members,
mir-302a, b, c and d, in one intact intronic cluster
(mir-302s; Supplementary Figure S1A) (8). Upon doxycyc-
line (Dox) stimulation, the biogenesis of mir-302 followed
the natural intronic miRNA pathway, in which mir-302
was transcribed with a gene encoded for red ﬂuorescent
protein (RGFP) and then further spliced into individual
mir-302 members by spliceosomal components and cyto-
plasmic RNaseIII Dicers (Figure 1B) (6). MiRNA micro-
array analysis revealed that all mir-302 members except
mir-302b* were efﬁciently expressed in transfected hHFCs
after Dox stimulation (Supplementary Figure 1B). The
procedure for generating mir-302-induced pluripotent
stem (mirPS) cells is summarized in Supplementary
Figure 2. Through this inducible mir-302 expression
mechanism, we investigated the functional role of
mir-302 in human SCR.
MATERIALS AND METHODS
Cell culture and electroporation
hHFCs were isolated and dissociated from a minimum of
two hair dermal papillae by 4mg/ml collagenase I diges-
tion for 45min in fresh RPMI 1640 medium supplemented
with 20% FBS. For culturing melanocytes, the isolated
cells were cultivated in Medium 254 with the addition of
human melanocytes growth supplement-2 (HMGS-2,
Invitrogen, Carlsbad, CA, USA) in the absence of anti-
biotics at 37 C under 5% CO2. For culturing ﬁbroblasts
(hFB), the isolated cells were cultivated in Medium 106
with the addition of low serum growth supplement (LSGS,
Invitrogen) in the absence of antibiotics at 37 C under 5%
CO2. Cultures were passaged at 70–80% conﬂuency by
exposing cells to trypsin/EDTA solution for 1min and
rinsing once with phenol red-free DMEM medium
(Invitrogen), and the detached cells were replated at 1:10
dilution in fresh Medium 254 with HMGS-2 or Medium
106 with LSGS, respectively. For electroporation, a
mixture of pTet-On-tTS-mir302s (10mg) and pTet-On-
Adv-Neo( ) (50mg) was added with the isolated hHFCs
(20000–50000) in a hypoosmolar buffer (200ml;
Eppendorf, Westbury, NY, USA) and electroporation
was performed using Eppendorf Multiporator at 300–
400V for 150ms. The electroporated cells were ﬁrst
grown in phenol red-free DMEM medium (Invitrogen)
supplemented with 20% knockout serum, 1% MEM
non-essential amino acids, 10ng/ml bFGF, 1mM
GlutaMax and 1mM sodium pyruvate, for 24h at 37 C
under 5% CO2. Then, 850mg/ml G418 and >3.75mg/ml
doxycycline (Dox) were added into the medium. The
medium and antibiotics were refreshed daily for 3–5
days till the cells expressed strong red ﬂuorescent RGFP.
Next, the individual red ﬂuorescent cell (mirPS) was moni-
tored under a TE2000 inverted microscopic system
(Nikon, Melville, NY, USA) and separately collected
into a 96 well, using MO-188NE 3D micromanipulators
(Nikon). In the absence of Dox, the mirPS cells were
grown and passaged in knockout DMEM/F-12 medium
(Invitrogen) supplemented with 20% knockout serum,
1% MEM non-essential amino acids, 100mM
ß-mercaptoethanol, 1mM GlutaMax, 1mM sodium
pyruvate, 10ng/ml bFGF, 100IU/ml penicillin/
100mg/ml streptomycin/ 250mg/ml G418, 0.1mM A83-01
and 0.1mM valproic acid (Stemgent, San Diego, CA,
USA), at 37 C under 5% CO2. Alternatively, in the
presence of Dox (2.5–5mg/ml; Sigma-Aldrich, St. Louis,
MO, USA), the mirPS cells were cultivated and passaged
in the same feeder-free cultural condition with addition of
0.05mM GSK inhibitor SB216763 (Stemgent). Addition of
GSK inhibitor could facilitate mirPS cell proliferation but
with a slight tendency to cause neural differentiation. For
neural cell induction, the mirPS cells were grown in the
above feeder-free cultural condition with 0.05mM
SB216763 but no Dox.
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(RGFP-mir-302s)
The mir-302 familial cluster (mir-302s) was generated as
reported earlier (6). The mir-302s consists of four parts,
including precursor miRNAs (pre-miRNAs) of mir-302a,
b, c and d. Synthetic oligonucleotides (Sigma-Genosys, St
Louis, MO, USA) were listed in Supplementary Table S1.
For expression, we mixed an equal amount (1:1) of the
mir-302s cluster and a pre-made SpRNAi-RGFP transgene
vector from our previous study (6), and then digested the
mixture with MluI/Pvu1 restriction enzymes at 37 C for
4h. The digested mixture was collected with a gel extrac-
tion ﬁlter in 30ml of ddH2O and ligated together with T4
DNA ligase at 8 C for 16h. This formed the RGFP-mir-
302s transgene, which could be further cleaved out of the
vector with XhoI/HindIII digestion.
Construction of the inducible pTet-On-tTS-mir302s vector
We ﬁrst modiﬁed a Dox-inducible pSingle-tTS-shRNA
vector (Clontech, Palo Alto, CA, USA) by replacing its
Figure 1. Inducible mir-302 expression and its effect on hHFC reprogramming. (A) Construct of the Dox-inducible pTet-On-tTS-miR302s vector.
(B) Mechanism of intronic mir-302 biogenesis. (C) Northern and western blot analyses of the dose-dependent mir-302 effect on the expression of core
reprogramming factors and melanocytic marker genes (n=5, P<0.01). (D) Northern blot analysis of the time-course mir-302 effect on Oct3/4–
Sox2–Nanog co-activation and SCR (n=5, P<0.01). (E) Northern blot analysis of hES marker gene expression induced by a high mir-302
concentration in mirPS cells compared to those in hES WA01-H1 (H1) and WA09-H9 (H9) cells (n=5, P<0.01). (F) FACS ﬂow cytometry
sorting of positively reprogrammed cells (mirPS-hHFC) with dual expression of mir-302 maker RGFP and hES cell marker Oct3/4.
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pTRE-Tight plasmid (Clontech). Then, the modiﬁed
vector was digested with XhoI/HindIII restriction
enzymes at 37 C for 4h, puriﬁed by a gel extraction
ﬁlter in 30ml of ddH2O, and then mixed and ligated with
the XhoI/HindIII-cleaved RGFP-mir-302s transgene (1:1)
with T4 DNA ligase at 8 C for 16h. This formed the in-
ducible pTet-On-tTS-mir302s vector.
Immunostaining assay
Embedding, sectioning and immunostaining tissue
samples were performed as reported (6). Primary
antibodies included Tuj1 (Abcam Inc., Cambridge, MA,
USA), ABCA2 (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), COL1A1 (Santa Cruz), COL2A1 (Santa
Cruz), M-cadherin (Abcam), MUC2 (Abcam), MUC5B
(Abcam), CD13 (Santa Cruz), CD105 (Abcam), keratin
14 (Abcam), keratin 16 (Abcam), Mitf (Abcam), TRP1
(Santa Cruz), a-SMA (Abcam), ED-A ﬁbronectin (Santa
Cruz), GAD67 (Abcam), EN4 (Abcam), SC (Abcam),
BMP11 (Abcam), cTnT (Abcam), myosin HC (Abcam)
and RGFP (Clontech). Fluorescent dye-labeled goat
anti-rabbit or horse anti-mouse antibody was used as the
secondary antibody (Invitrogen, Molecular Probes).
Positive results were examined and analyzed at  100 or
 200 magniﬁcation under a ﬂuorescent 80i microscopic
quantitation system with a Metamorph imaging program
(Nikon).
Northern blot analysis
Total RNAs (10mg) were isolated with a mirVana
TM
miRNA isolation kit (Ambion, Austin, TX, USA),
fractionated by either 15% TBE-urea polyacrylamide gel
or 3.5% low melting point agarose gel electrophoresis, and
electroblotted onto a nylon membrane. Detection of
mir-302 was performed with a locked nucleic acid
[LNA]-DNA probe (50-[TCACTGAAAC]ATGGAAGC
ACTTA-30), while probes for other gene detection were
synthesized and listed in Supplementary Table S2. All
probes were puriﬁed by high-performance liquid chroma-
tography and tail labeled with terminal transferase (20U)
for 20min in the presence of [
32P]-dATP (>3000Ci/mM,
Amersham International, Arlington Heights, IL, USA).
Anti-miRNA oligonucleotide transfection
For mir-302 knockdown assay, we encapsulated the above
anti-mir-302 [LNA]-DNA probe (2–10mg/ml) with a
FuGENE HD reagent (Roche, Indianapolis, IA, USA)
and applied to cell cultures at  30–40% conﬂuency. Cell
culture medium was refreshed 12-h post-treatment. The
mir-302-knockdown rate was determined by northern
blot analysis at 24-h post-treatment.
Western blot analysis
Western blotting was performed as reported (6). Major
primary antibodies in this study included Oct3/4 (Santa
Cruz), SSEA-1 (Santa Cruz), SSEA-3 (Santa Cruz),
SSEA-4 (Santa Cruz), Sox2 (Santa Cruz), Nanog (Santa
Cruz), Klf4 (Santa Cruz), Lin28 (Abcam), UTF1
(Abcam), DNMT1 (Abcam), HDAC2 (Abcam),
H3K4me2/3 (Abcam), AID/AICDA (Santa Cruz),
AOF1 (Abcam), AOF2 (Sigma), MECP1-p66 (Millipore,
Billerica, MA), MECP2 (Abcam), TRP1 (Santa Cruz),
keratin 16 (Abcam), b-actin (Chemicon, Temecula, CA,
USA) and RGFP (Clontech).
Luciferase 30-UTR reporter assay
Luciferase assays were performed using the pMir-Report
miRNA Expression Reporter Vector System (Ambion),
according to the manufacturer’s instruction. The mir-302
target sites (normal and/or mutant) were inserted in the
30-UTR cloning site of the pMir-Report Luciferase
Reporter vector. The two target sites were synthesized
and separated by 12-CAGT-repeats. Another pMir-
Report ß-gal Control vector was used as a no reporter
control. We transfected 200ng of the reporter vector
into 50000 mirPS cells in the absence or presence of
Dox treatment, using a FuGene HD reagent (Roche) fol-
lowing the manufacturer’s suggestion. Cell lysates were
harvested 48h after transfection, and the knockdown
levels of luciferase were normalized and shown by ratios
of relative luciferase activity (RFA), which was calculated
by the level of luciferase activity in Dox-treated (Dox-on)
mirPS cells divided by that of untreated (Dox-off)
mirPS cells. Mir-434-expressing cells generated by
electroporating hHFCs with pTet-On-tTS-miR434-5p
were served as a negative control.
Bisulﬁte DNA sequencing
Genomic DNAs were isolated from about two million
cells using a DNA isolation kit (Roche) and 1mg of the
isolated DNAs were further treated with bisulﬁte
(CpGenome DNA modiﬁcation kit, Chemicon,
Temecula, CA, USA), according to the manufacturers’
suggestions. Meanwhile, 2mg of untreated DNAs were
digested with a CCGG-cutting restriction enzyme HpaII
and then analyzed by 1% agarose gel electrophoresis to
determine genome-wide demethylation. The treatment
with bisulﬁte converted all unmethylated cytosine to
uracil, while methylated cytosine remained as cytosine.
For bisulﬁte DNA sequencing analyses, we ampliﬁed the
promoter regions of Oct3/4 and Nanog with PCR. Primers
included 50-GAGGCTGGAGCAGAAGGATTGCTTTG
G-30 and 50-CCCTCCTGAC CCATCACCTCCACCAC
C-30 for Oct3/4, and 50-TGGTTAGGTTGGTTTTAAA
T TTTTG-30 and 50-AACCCACCCTTATAAATTCTC
AATTA-30 for Nanog (1). The bisulﬁte-modiﬁed DNAs
(50ng) were ﬁrst mixed with the primers (total 100pmol)
in 1  PCR buffer, heated to 94 C for 2min, and immedi-
ately cooled on ice. Next, 25 cycles of PCR were per-
formed as follows: 94 C for 1min and 70 C for 3min,
using an Expand High Fidelity PCR kit (Roche). The
ampliﬁed DNA product with a correct size was further
fractionized by 3% agarose gel electrophoresis, puriﬁed
with a gel extraction ﬁlter (Qiagen), and then used in
DNA sequencing. A detailed proﬁle of the DNA methy-
lation sites was generated by comparing the unchanged
cytosine in the converted DNA sequence to the unconvert-
ed one.
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Microarray analyses were performed as reported earlier
(6). Human genome GeneChip U133 plus 2.0 arrays
(Affymetrix, Santa Clara, CA, USA) were used to detect
the alterations of over 47000 human gene expression
patterns in tested cells, while miRNA microarray
analyses were done by LC Sciences (San Diego, CA,
USA). Total RNAs from each tested sample were
isolated using a mirVana
TM miRNA isolation kit
(Ambion), following the manufacturer’s suggestion. The
purity and quantity of isolated RNAs were assessed using
1% formaldehyde–agarose gel electrophoresis and spec-
trophotometer measurement (Bio-Rad). The sample
signals were normalized using the total average difference
between perfectly matched probes and mismatched
probes. Alterations of genome-wide gene expression
patterns were analyzed using Affymetrix Microarray
Suite version 5.0, Expression Console
TM version 1.1.1
(Affymetrix) and Genesprings (Silicon Genetics) soft-
wares. Changes in gene expression rates >1-fold were con-
sidered as positive differential genes. For gene clustering, a
plug-in program Genetrix (Epicenter Software) was used
in conjunction with the Affymetrix softwares. Signals of
the sample were normalized with the internal housekeep-
ing control average in each microarray.
Implantation and teratoma formation
Approximately 5–10 mirPS or mirPS-NT cell-derived
embryoid bodies (4- to 16-cell-stage) were suspended in
50ml of a mixture of DMEM and Matrigel (2:1),
followed by implantation into the uterus of a 6-week-old
female pseudopregnant immunocompromised SCID-beige
mouse. The pseudopregnant mice were prepared by
intraperitoneal injection of 1IU human menopausal go-
nadotrophin for 2 days and then human chorionic go-
nadotrophin (hCG) for one more day. The cells and
mice were not treated with Dox before or after implant-
ation. The mice were anesthetized with 2.5% Avertin
solution, 0.4ml per mouse during implantation.
Xenografted masses were monitored 3–4 weeks after the
implantation or when the sizes were grown to >100mm
3.
Cysts/teratomas were dissected and the volumes were
calculated using the formula (length width
2)/2. Cyst/
teratoma lesions were counted, weighed and subjected to
further histological analysis. Formation of teratoma-like
tissue cysts was usually observed at  2.5-week
post-implantation.
Microinjection
Microinjection was performed on the nuclei of cells plated
8–12h before on a collagen-coated glass coverslip. Cells
were microinjected using a set of Eppendorf microinjector
and MO-188NE 3D hydraulic micromanipulators
mounted on a Nikon TE2000 microscope system with
duration and pressure settings of 0.5s and 30hectopascals,
respectively. The microinjection buffer contained 10mg/ml
AOF2, 2mg/ml ﬂuorescein (FITC)-labeled dextran dye,
10mMNaH2PO4 and 70mM KCl, pH 7.2. After injection,
cells were cultivated in the feeder-free mirPS cell cultural
condition with addition of 0.05mM SB216763.
Nuclear transfer
MirPS cell cytoplasm with different concentrations of
mir-302 was prepared by varying in Dox treatments
(from 1.0, 5.0, 10.0 to 20.0mg/ml). The concentrations of
cytoplasmic mir-302 were conﬁrmed by northern blot
analysis. Hybrids [mirPS-nuclear transfer (NT) cells] of
mirPS cell cytoplasm and hFB nuclei were generated
using a set of MO-188NE 3D hydraulic ﬁne/coarse
micromanipulators and micro-injectors/holders under a
TE2000 inverted microscopic system (Nikon). The
mirPS-NT cells were then grown in knockout DMEM/
F-12 medium (Invitrogen) supplemented with 20%
knockout serum, 1% MEM non-essential amino acids,
100mM b-mercaptoethanol, 1mM GlutaMax, 1mM
sodium pyruvate, 10ng/ml bFGF, 100IU/ml penicillin/
100mg/ml streptomycin, 0.1mM A83-01 and 0.1mM
valproic acid, at 37 C under 5% CO2.
DNA ﬁngerprinting
PCR was used to amplify the variable numbers of tandem
repeats (VNTR) of the D1S80 locus on human chromo-
some 1. Genomic DNAs were isolated with a DNA isola-
tion kit (Roche) and 50ng of the DNAs were ampliﬁed by
PCR with primers 50-GAAACTGGCCTCCAAACACT
GCCCGCCG-30 and 50-GTCTTGTTGGAGATGCACG
T GCCCCTTGC-30 (50pmol each). PCR was performed
as follows: one cycle at 94 C for 4min and then 30 cycles
through 94 C for 30s, 68 C for 30s and 72 C for 2min,
using the Expand High Fidelity PCR kit (Roche). The
ampliﬁed DNAs were further fractionized by 2.5%
agarose gel electrophoresis.
Statistic analysis
Any change over 75% of signal intensity in the analyses of
immunostaining, western blotting and northern blotting
was considered as a positive result, which in turn was
analyzed and presented as mean±SE. Statistical
analysis of data was performed by one-way ANOVA.
When main effects were signiﬁcant, the Dunnett’s
post-hoc test was used to identify the groups that
differed signiﬁcantly from the controls. For pairwise com-
parison between two treatment groups, the two-tailed
student t-test was used. For experiments involving more
than two treatment groups, ANOVA was performed
followed by a post hoc multiple range test. Probability
values of P<0.05 was considered signiﬁcant. All
P-values were determined from two-tailed tests.
RESULTS
Mir-302-induced SCR is a dose-dependent mechanism
involving AOF2 suppression and Oct3/4–Sox2–Nanog
co-activation
Mir-302-mediated gene silencing is a dose-dependent
reaction due to its mismatched targeting. Following an
increase of Dox concentration up to 10mM, we observed
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was proportionally elevated, while expressions of
melanocytic markers tyrosinase-related protein 1 (TRP1)
and keratin 16 were reduced in all transfected cells
(Figure 1C). Accordingly, core reprogramming factors
Oct3/4, Sox2 and Nanog were all strongly stimulated by
a threshold of Dox  7.5mM, indicating a dose-dependent
correlation between mir-302 concentration and Oct3/4–
Sox2–Nanog co-activation. This concurrent Oct3/4–
Sox2–Nanog gene activation is an essential step for iPS
cell induction (2,3). Time-course measurement of
reprogramming hHFCs to mirPS cells further showed
that the Oct3/4–Sox2–Nanog co-activation was most
prominent after Days 5–6, the time frame required for
initiating SCR (Figure 1D). Almost no cell division was
detected during the ﬁrst 3–4 days after treatment of
 7.5mM Dox. In this dose-dependent SCR process
(Figure 1C), we discovered three critical mir-302 concen-
trations. First, at the treatment of 5mM Dox, the induced
mir-302 level was closely similar to that found in hES H1
and H9 cells, but not sufﬁcient to reprogram hHFCs.
Second, at 7.5mM Dox, mir-302 concentration was
raised to over 30% higher than that of H1 and H9 cells
and began inducing co-expression of the core
reprogramming factors Oct3/4–Sox2–Nanog and Lin28
(Figure 1E). Last, at 10mM Dox, the stimulated mir-302
concentration was optimal for reprogramming hHFCs to
mirPS cells and forming embryoid bodies. Treatment of
>12mM Dox caused severe cell cycle arrest at the G0/G1
phase, which ultimately hindered mirPS cell formation.
Fluorescence-activated cell sorter (FACS) analysis
further conﬁrmed that 91% of the transfected cells
treated with 10mM Dox expressed over twice more
Oct3/4 than those treated with only 5mM Dox
(Figure 1F). For the ﬁrst time, this study established the
threshold concentration of a hES-speciﬁc miRNA for
SCR. The mechanism underlying this SCR process is con-
sistent with the reported iPS cell induction using ectopic
transfection of Oct3/4–Sox2–Nanog–Lin28 factors (2).
Following the increase of Dox-induced mir-302 expres-
sion, we also observed a signiﬁcant change of mirPS cell
colony morphology from hES-cell-like 2D aggregations
(at 7.5mM Dox) to embryoid body (EB)-like three-
dimensional colonies (at 10mM Dox), which highly
resembled early mammalian zygotes (Figure 2A). After
cultivated on a low attachment (overhanging) surface,
these EB-like colonies formed sphere-like EBs strongly
and homogeneously expressing pluripotent Oct3/4–Sox2–
Nanog markers as well as other standard hES markers
(Figure 2B and C), indicating that their undifferentiated
status was well maintained by the induced mir-302. A
similar undifferentiated status is often observed in mam-
malian zygotes before the morula stage, but rarely in
three/four-factor-induced iPS cell colonies. This is
probably due to a lower mir-302 level expressed in both
human iPS and late blastocyst-derived hES cells (9). From
morphology and hES-speciﬁc gene expression, there was
no signiﬁcant difference between mirPS cell colonies and
mirPS cell-derived EBs. Accompanying the Oct3/4–Sox2–
Nanog co-activation, we also found a proportional loss of
multiple epigenetic regulator expression, including AOF1,
AOF2, MECP1-p66 and MECP2 (Figure 1C). Western
blot analysis showed that hHFCs expressed abundant
AOF2 and MECP1/2 but scarce AOF1, suggesting that
silencing of AOF2 plays a major role in hHFC
reprogramming. Deﬁciency of either AOF1 or AOF2 is
sufﬁcient to cause global demethylation (13,14). Our
previous studies have also demonstrated that mir-302
mediated MECP1/2 silencing enhances global
demethylation (6,15). Therefore, mir-302 induces SCR
through a combinatory mechanism involving both Oct3/
4–Sox2–Nanog co-activation and AOF1/2 suppression,
while further MECP1/2 silencing enhances the result of
AOF1/2-associated global demethylation.
Mir-302 silences AOF2 to trigger DNMT1 deﬁciency
and global demethylation
To validate the interactions between mir-302 and its epi-
genetic targets, we used a luciferase 30-untranslated region
(30-UTR) reporter assay (Figure 3A), which showed that
treatments with various mir-302 concentrations resulted in
different epigenetic patterns in mirPS cells. In the presence
of 10mM Dox, mir-302 effectively bound to the target sites
of AOF1, AOF2, MECP1-p66 and MECP2 mRNAs and
successfully silenced over 80% of the reporter luciferase
expression in all targets (Figure 3B). Suppression of the
real target genes in mirPS cells was also conﬁrmed
by western blot analyses, consistent with the results of
the luciferase 30-UTR reporter assay (Figure 3C).
Accordingly, we detected a signiﬁcant decrease of
DNMT1 (loss over 87±3% of the level in hHFCs) and
increase of H3K4 di-/tri-methylation (H3K4me2/3; gain
103±17%) in response to the silencing of AOF2 (loss
93±2%) by mir-302. Previous studies have demonstrated
that AOF2 is required for stabilizing DNA
methyltransferase 1 (DNMT1) and preserving its activity
on the maintenance of global DNA methylation (14),
whereas active global demethylation can promote Oct3/
4–Nanog activation in early mouse embryos and mouse–
human fused heterokaryons (17,18). Conceivably, the
deﬁciency of DNMT1 caused mirPS cell genomes to be
susceptible to a certain demethylation activity. This
demethylation effect was further enhanced by
co-suppression of MECP1/2 (loss 96±1% and
81±5%, respectively) (6) and eventually led to global
demethylation and Oct3/4–Nanog activation (Figure 4A
and B). On the ﬂipside, a lower mir-302 concentration
induced by 5mM Dox failed to trigger any signiﬁcant
silencing effect on either the target sites of the reporter
gene or the targeted epigenetic genes, except
MECP1-p66, indicating that mir-302-induced global
demethylation is dose dependent and requires
co-suppression of AOF1/2 and MECP1/2 (Figure 3B
and D).
Methylation site-sensitive HpaII digestion assays con-
ﬁrmed that mirPS cell genomes isolated from the group
treated with 10mM Dox underwent global demethylation
(Figure 4A). When further assessing the methylation
patterns of Oct3/4 and Nanog promoters with bisulﬁte
DNA sequencing, we observed that both promoters were
almost completely demethylated in a fashion resembling
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demethylation patterns have also been found in iPS cells
(2,3). In contrast, neither global demethylation nor SCR
was observed in the transfected cells treated with only
5mM of Dox (Figures 1C, 4A and B). We subsequently
evaluated this global demethylation effect in over 47000
human gene expression patterns using microarray analyses
and revealed that approximately half of the transcriptome
expression in mirPS cells was changed from a somatic
hHFC mode to a uniform hES-like expression pattern
sharing over 91% similarity to that of H1/H9 cells
(Figure 4C). Hierarchical clustering of the top 30 most
differentially expressed hES-speciﬁc genes and epigenetic
regulators in microarrays further showed an extremely
high correlation between reprogrammed mirPS and hES
H1/H9 cells (Figure 4D). Thus, we conclude that mir-302
regulates the epigenetic reprogramming of genomic
methylation patterns through co-suppression of AOF2
and DNMT1 during SCR.
Mir-302-induced SCR is reversible and dependent on
AOF2–DNMT1 suppression
After SCR completion (5–6 days post-transfection of
mir-302), reprogrammed mirPS cells were visually distin-
guished by their sphere-shape morphology and expression
of red ﬂuorescent RGFP protein (Supplementary Figure
S3A), and further selected by G418 antibiotics to ensure
their purity. Consistent with our previous reports (6,15),
each individual mirPS cell could grow into a homogeneous
EB (Supplementary Figure S3B) and form teratoma-like
tissue cysts (Figure 5C) in immunocompromised
SCID-beige mice, containing various differentiated
tissues derived from all three embryonic germ layers,
ectoderm, mesoderm and deﬁnitive endoderm
(Figure 5D). These results conﬁrmed the hES cell-like
pluripotency of mirPS cells.
Next, we evaluated the role of mir-302–targeted AOF2
silencing in the process of SCR using recombinant AOF2
protein and its inhibitor tranylcypromine (Figure 5A).
Under conditions of 10mM Dox stimulation, the success
rate of complete SCR approached 100% (477/480). After
that, the reprogrammed mirPS cells could be cultivated to
over 26–28 passages under our feeder-free cultural condi-
tion in the absence of Dox and GSK inhibitor (‘Materials
and Methods’ section), indicating the completion of SCR.
However, when a GSK inhibitor was presented in the
cultural medium without sufﬁcient Dox stimulation,
majority of mirPS cells differentiated into neuron-like
cells. Given that glycogen synthase kinase 3 (GSK3) is a
major gatekeeper for embryonic neural induction (19), this
result suggests that GSK inhibitor can induce the
Figure 2. Morphological and genetic changes of mirPS cell properties in response to different mir-302 concentrations. (A) Morphological changes of
mirPS cell colonies in response to Dox-induced mir-302 expression. Mir-434-expressing cells generated by electroporating hHFCs with
pTet-On-tTS-miR434-5p were served as a negative control. A morphological comparison between a morula-staged rat embryo and a mirPS cell
colony at 32–64 cell stage was shown in the lower panel. (B) Fluorescent microscope examination showing strong and homogeneous expression of the
core pluripotent stem cell markers Oct3/4, Sox2 and Nanog in a mirPS-derived embryoid body. BF-DIC, bright ﬁeld with differential interference
contrast. (C) Western blotting conﬁrming the expression patterns of major hES-speciﬁc marker proteins in completely (10mM Dox) and partially
(5mM Dox) reprogrammed mirPS cells compared to those found in hES H1 and H9 cells (n=4,P<0.01). Mir-302 expression was proportional to
Dox concentration.
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differentiated cells could be reprogrammed back to mirPS
cells after re-supplementation of  7.5mM Dox in the
cultural medium. The same neuronal differentiation
could also be triggered by treatment of 10mg/ml
anti-mir-302 LNA–DNA oligonucleotides in mirPS cells
(Figure 5A and B), indicating the critical role of mir-302
concentration in maintaining pluripotent cell stemness.
Alternatively, while being microinjected with recombinant
AOF2 into the cell nuclei, the differentiated cells failed to
be reprogrammed back to mirPS cells even after 10mM
Dox stimulation, demonstrating the inhibitory role of
AOF2 in the mechanism of mir-302-induced SCR.
Further treatment of tranylcypromine removed the
blockade of AOF2 in the process of SCR and, in conjunc-
tion with the stimulation of 10mM Dox, could again re-
program the differentiated cells to mirPS cells with all
hES-like properties. Microinjection of blank buffer did
not cause any effect in all tests. Therefore, SCR is a re-
versible mechanism dependent on mir-302–mediated
AOF2 silencing.
Following this reversible SCR process, we measured the
corresponding changes of global demethylation, AOF2–
DNMT1 co-suppression and Oct3/4–Sox2–Nanog
co-activation in all tested mirPS and differentiated cells.
Bisulﬁte DNA sequencing assays revealed that, under the
GSK inhibitor inﬂuence, the global demethylation of
Oct3/4 and Nanog promoters were observed only in
mirPS cells treated with  7.5mM Dox (mirPS+10mM
Dox) and the re-reprogrammed cells co-treated with
10mM Dox, AOF2 and tranylcypromine (mirPS+10mM
Dox–AOF2), whereas the differentiated cells treated
with 10mM Dox and AOF2 (mirPS+10mM Dox+AOF2)
failed to complete the demethylation (Figure 5E).
These resulting global demethylation patterns per-
fectly matched the morphological changes observed in
Figure 3. Analysis of mir-302-induced silencing effects on targeted epigenetic genes and global demethylation. (A) Constructs of the luciferase
30-UTR reporter genes, which carry either two normal (T1+T2) or two mutant (M1+M2), or a mixture of both (T1+M2 or M1+T2), mir-302
target sites in the 30-UTR. The mutant sites contained a mismatched TCC motif in place of the uniform 30-CTT end of the normal target sites.
(B) Effects of Dox-induced mir-302 on the luciferase expression (n=5, P<0.01). (C) and (D) Western blot analyses showing the changes of
major mir-302-targeted epigenetic gene expression induced by high (10mM Dox) and low (5mM Dox) mir-302 concentrations in mirPS cells
compared to those found in hES H1 and H9 cells (n=4, P<0.01).
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showed that the simultaneous AOF2–DNMT1 co-
suppression and Oct3/4–Sox2–Nanog co-activation only
occurred in the mirPS+10mM Dox and mirPS+10mM
Dox–AOF2 cells but not in mirPS+10mM Dox+AOF2
cells (Figure 5F), conﬁrming that mir-302–targeted
AOF2 silencing is required for global demethylation
during SCR. In accordance to this counteraction
between mir-302 and AOF2, we identiﬁed that SCR is a
reversible process.
Figure 4. Mir-302-induced genomic DNA demethylation and global gene expression alteration. (A) HpaII cleavage showing the vast loss of global
CpG methylation, identiﬁed by increased presence of smaller DNA fragments, at a genome-wide scale in mirPS cells treated with 10mM but not 5mM
Dox. (B) Bisulﬁte DNA sequencing in the promoter regions of Oct3/4 and Nanog. Methylation maps show the most frequently observed patterns.
Black and white circles indicate the methylated and unmethylated cytosine sites, respectively. (C) Analysis of global gene expression patterns before
and after global demethylation, using human genome GeneChip U133 plus 2.0 arrays (Affymetrix; n=3,P<0.01–0.05). (D) Microarray hierarchical
clustering of the top 30 most differentially expressed hES-speciﬁc genes and epigenetic regulators between somatic hHFCs, reprogrammed
mirPS-hHFCs (mirPS+10mM Dox) and hES H1/H9 cells.
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nuclear effector
Mir-302 is a cytoplasmic effector. To further rule out the
possible involvement of any nuclear factor from the
mir-302–mediated global demethylation, we transferred
human adult ﬁbroblast (hFB) nuclei into the cytoplasm
of mirPS cells pre-treated with 10mM Dox. Most (93%)
of the hybrid cells successfully formed mirPS-like iPS cells
and embryoid bodies (Figure 6A). When cytoplasm
derived from the mirPS cells pre-treated with <7.5mM
Dox, neither mirPS-like cell nor embryoid body was
developed. Conversely, transfer of mirPS nuclei into
hFB cytoplasm also failed to form any viable cells.
Thus, the reprogramming ability of mirPS cells is
preserved in the cytoplasm rather than nucleus. These
hFB nucleus-transferred mirPS (mirPS-NT) cells
preserved all the same traits as mirPS cells in terms of
global demethylation (Figure 6B and C), Oct3/4–Sox2–
Nanog co-activation and AOF2–DNMT1 co-suppression
(Figure 6D), and in vivo pluripotency (Figure 6F and
Supplementary Figure 4). Using DNA ﬁngerprinting in
human D1S80 alleles, the mirPS-NT-derived teratoma
cysts were conﬁrmed to be originated from human cell
Figure 5. Reversible SCR process regulated by mir-302–mediated AOF2 silencing. (A) Reversible interchange between hES-like mirPS and
neuron-like differentiated cells as a result of mir-302 and AOF2 counteraction. (B) Northern blots showing the mir-302 knockdown ( 65%) by
10mg/ml anti-mir-302 LNA–DNA oligonucleotides. (C) Typical morphology of a mirPS EB-derived teratoma-like tissue cyst (2.5 weeks
post-implantation). (D) Pluripotent differentiation of mirPS-hHFCs into teratoma-like cysts containing various tissues derived from all three em-
bryonic germ layers. Immunostaining the cross-sections of mirPS EB-derived tissue cysts showed the positive results of speciﬁc differentiation
markers, including neuronal b-tubulin isotype-III (Tuj1; green) and/or ATP-binding cassette sub-family A member 2 (ABCA2; blue), cartilage
collagen type II a-1 (COL2A1; green), muscle-associated M-cadherin (green), gut-epithelium-related mucin 2 (MUC2; green), and glandular
epithelium-related CD13 (green). Photographs were taken with Nikon TE2000 microscopic system at  200 magniﬁcation. (E) Global demethylation
patterns in Oct3/4 and Nanog promoters corresponding to the result of (A). (F) Changes of Oct3/4, Sox2, Nanog, AOF2 and DNMT1 expression in
response to the results of (A) and (E).
Nucleic Acids Research,2011, Vol.39, No. 3 1063sources rather than mouse cells (Figure 6E). In view of
these hES-like properties inherent in mirPS-NT cells, we
conclude that mir-302 is able to not only induce SCR but
also preserve this reprogramming ability in the cytoplasm
of mirPS cells.
DISCUSSION
Our previous study established that mir-302 functions not
only to improve the efﬁciency of SCR but also to enhance
the stemness and pluripotency of the reprogrammed
somatic cells (6,15). In this study, we further revealed
the mechanism involved (Figure 6G), showing that
mir-302 signiﬁcantly decreases AOF2 and DNMT1
activities and, in conjunction with the co-suppression of
MECP1/2, results in global genomic DNA demethylation
and H3K4 modiﬁcation. Subsequently, these epigenetic
reprogramming events induce hES-speciﬁc gene expres-
sion, in particular Oct3/4, Sox2 and Nanog, which in
turn further stimulates mir-302 expression, and so on to
Figure 6. Assessment of the reprogramming ability preserved in mirPS cytoplasm. (A) Embryoid body derived from a single mirPS–hFB hybrid
(mirPS-NT) cell after limiting dilution. Scale bars=100mm. (B) HpaII cleavage showing global demethylation (smaller DNA fragments) in
reprogrammed mirPS-NT cells compared to that in the somatic hHFC and hFB cells. (C) Bisulﬁte DNA sequencing in the Oct3/4 and Nanog
promoters, showing CpG methylation maps. Black and white circles indicate the methylated and unmethylated cytosine sites, respectively.
(D) Northern and western blot analyses of mir-302, AOF2–DNMT1 and Oct3/4–Sox2–Nanog expression patterns in mirPS-NT cells compared to
those in the somatic hFB and reprogrammed mirPS (mirPS+Dox) cells. (E) DNA ﬁngerprinting of the variable numbers of tandem repeats (VNTRs)
in the D1S80 locus of human genome, conﬁrming that mirPS-NT, mirPS-hHFC and hFB cells all originated from the same human source not mouse.
(F) Pluripotent tissue types found in teratoma-like cysts derived from mirPS-NT cells. Markers (green): keratin 14, actin a-2 in smooth muscle aorta
(a-SMS, ACTA2), CD105 and MUC2. H&E, histological staining with hematoxylin and eosin. BF, bright ﬁeld. (G) Proposed mechanism of mir-302–
induced SCR.
1064 Nucleic Acids Research, 2011,Vol.39, No. 3form a positive feedback cycle essential for maintaining
SCR. When compared to the previous three/four-factor
reprogramming methods, our approach adopts a novel
entry point in the same mechanistic cycle to complete
SCR. Also, without introducing the oncogenic Klf4 and
c-Myc genes, this new approach likely provides safer
in vivo applications. From this novel SCR mechanism,
we learned that the effector(s) responsible for
reprogramming genomic epigenetics resides in the mirPS
cytoplasm and can enter somatic cell nuclei after NT
because mir-302 is a cytoplasmic effector. Thus, our
ﬁndings may also help in clarifying the mechanism of
somatic cell NT, addressing the possible role of mir-302
in nuclear reprogramming.
Through deciphering the interactions between mir-302
and its targeted epigenetic genes, we elucidate the intricate
gene regulation circuitry involved in epigenetic
reprogramming during SCR. Global demethylation natur-
ally occurs in two developmental periods—at the initial
stage of gametogenesis and during early embryogenesis
up until the morula stage (20). The mir-302 expression
pattern in human embryos has not been studied due to
ethical and legal conﬂicts. However, its homologous
counterpart mir-291/294/295 in mice was found to
present most abundantly during these two developmental
periods (21). Previous studies in mice have also shown that
deﬁciency of AOF2 and DNMT1 activities occurs most
signiﬁcantly during the same embryogenesis period of
time (14). To this, our ﬁnding of mir-302-targeted AOF2
silencing connects the relationship of all these events and
further extends the presence of this epigenetic
reprogramming mechanism in iPS cells during SCR. In
this extended model, cell stemness, analogous to a
fountain of youth, is inherent in our somatic cells and
can be activated and regulated by mir-302, providing a
feasible means to rejuvenate cell stemness and pluripotency
through mimicking the natural reprogramming pathway.
However, our current work only reveals its partial func-
tionality. To fully utilize this profound mechanism of
mir-302, further studies are still needed to realize its poten-
tial in stem cell research and regenerative medicine.
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